Key facts
- This page summarizes John J. Wiesehan III's Form 4 filing for cbdMD, Inc. (YCBD).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Sep 2021, 18:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Additional SEC filing notes
Footnote F1
The common stock was issued as partial consideration pursuant to that certain Asset Purchase Agreement dated July 22, 2021, by and among Twenty Two Capital, LLC ("Twenty Two"), the Issuer, the Reporting Person, and the other parties named therein, with 300,000 shares of common stock issued at closing of the Asset Purchase Agreement. On September 28, 2021, Twenty Two transferred a limited number of shares and distributed the remaining shares to its members on a pro rata basis. Represents the distribution of the shares by Twenty Two and the acquisition of the pro rata number of shares distributed to the Reporting Person, a member of Twenty Two as approved by the Issuer's board of directors and exempt under Section 16b-3.
Footnote F2
Represents the Reporting Person's pecuniary interest in the 300,000 shares of the Issuer acquired by Twenty Two pursuant to the APA. The Reporting Person is the holder of a 53.85% membership interest in Twenty Two and a manager of Twenty Two.